Navitoclax
Navitoclax (ABT-263) is a potent, orally bioavailable Bcl-2 family protein inhibitor that avidly binds Bcl-2, Bcl-xL, and Bcl-W (Ki < 1 nM for all three proteins).
| Catalog Number | T2101 |
| Alternative Name(s) | ABT-263 |
| Research Area | Apoptosis |
| Molecular Formula | C47H55ClF3N5O6S3 |
| CAS# | 923564-51-6 |
| Purity | 98.88% |
| SMILES | CC1(C)CCC(=C(CN2CCN(CC2)c2ccc(cc2)C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN3CCOCC3)CSc3ccccc3)c(c2)S(=O)(=O)C(F)(F)F)C1)c1ccc(Cl)cc1 |
| Size | 200 mg |
| Supplier Page | https://www.targetmol.com/compound/Navitoclax |
| Additional Information | https://www.targetmol.com/datasheet/T2101 |